3rd Quarter - Termination Amendment

FABIANI & COMPANY for AETHLON MEDICAL, INC.

Firm
Client
Income
$30,000
Expenses
—
Terminated
Sep 20, 2011

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Jan 13, 2012 $30,000 Replaced
3rd Quarter - Termination Amendment (this page) Apr 17, 2012 $30,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Development of extracorporeal hemofiltration systems for biodefense and combat casualty care.

LobbyistCovered position, as disclosed
ELIZABETH BARROWS —
MELISSA DUPREE —

Contacted: Defense Advanced Research Projects Agency (DARPA); Army, Dept of (Other)

Defense DEF

Development of extracorporeal hemofiltration systems for biodefense and combat casualty care.

LobbyistCovered position, as disclosed
ELIZABETH BARROWS —
MELISSA DUPREE —

Contacted: Army, Dept of (Other); Defense Advanced Research Projects Agency (DARPA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.